S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Realaus laiko atnaujinimai Coloplast A/S [CLPBY]

Birža: OTC Sektorius: Healthcare Pramonė: Medical Instruments & Supplies
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 0.00%

Atnaujinta3 geg. 2024 @ 22:59

2.99% $ 12.41

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 22:59):

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally...

Stats
Šios dienos apimtis 43 283.00
Vidutinė apimtis 109 106
Rinkos kapitalizacija 27.80B
EPS $0.598 ( 2023-06-30 )
Kita pelno data ( $0.0800 ) 2024-05-09
Last Dividend $0.0740 ( 2023-05-19 )
Next Dividend $0 ( N/A )
P/E 38.78
ATR14 $0.0210 (0.17%)

Tūris Koreliacija

Ilgas: -0.21 (neutral)
Trumpas: 0.88 (strong)
Signal:(45.765) Same movement expected

Coloplast A/S Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Coloplast A/S Koreliacija - Valiuta/Žaliavos

The country flag 0.71
( moderate )
The country flag 0.17
( neutral )
The country flag 0.00
( neutral )
The country flag 0.70
( moderate )
The country flag -0.06
( neutral )
The country flag 0.54
( weak )

Coloplast A/S Finansinės ataskaitos

Annual 2023
Pajamos: $24.50B
Bruto pelnas: $16.33B (66.64 %)
EPS: $22.21
FY 2023
Pajamos: $24.50B
Bruto pelnas: $16.33B (66.64 %)
EPS: $22.21
FY 2022
Pajamos: $22.58B
Bruto pelnas: $15.53B (68.78 %)
EPS: $22.15
FY 2021
Pajamos: $19.43B
Bruto pelnas: $13.31B (68.53 %)
EPS: $2.27

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0.210
(N/A)
$0
(N/A)
$0.0740
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Coloplast A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.57 - average (85.65%) | Divividend Growth Potential Score: 5.74 - Stable (14.79%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0810 2021-05-14
Last Dividend $0.0740 2023-05-19
Next Dividend $0 N/A
Payout Date 2023-05-30
Next Payout Date N/A
# dividends 5 --
Total Paid Out $0.649 --
Avg. Dividend % Per Year 0.00% --
Score 2.9 --
Div. Sustainability Score 6.57
Div.Growth Potential Score 5.74
Div. Directional Score 6.15 --
Next Divdend (Est)
(2024-10-01)
$0.00796 Estimate 3.61 %
Dividend Stability
0.29 Very Poor
Dividend Score
2.90
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PCLB Ex Dividend Knight 2023-09-01 Quarterly 0 0.00%
DIMC Ex Dividend Knight 2023-09-28 Quarterly 0 0.00%
UEPCO Ex Dividend Knight 2023-07-20 Quarterly 0 0.00%
JMPLY Ex Dividend Knight 2023-06-15 Semi-Annually 0 0.00%
BKHYY Ex Dividend Junior 2023-08-25 Annually 0 0.00%
RMYHY Ex Dividend Junior 2023-09-05 Semi-Annually 0 0.00%
EVSBY Ex Dividend Knight 2023-05-24 Annually 0 0.00%
WJRYF Ex Dividend Junior 2023-09-28 Annually 0 0.00%
LNSTY Ex Dividend Knight 2023-08-17 Semi-Annually 0 0.00%
CGEMY Ex Dividend Knight 2023-05-25 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1951.5006.119.16[0 - 0.5]
returnOnAssetsTTM0.1001.2006.667.99[0 - 0.3]
returnOnEquityTTM0.4241.5006.409.60[0.1 - 1]
payoutRatioTTM0.957-1.0000.433-0.433[0 - 1]
currentRatioTTM0.5320.800-2.34-1.871[1 - 3]
quickRatioTTM0.3240.800-2.80-2.24[0.8 - 2.5]
cashRatioTTM0.04841.500-0.842-1.263[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM9.311.0007.667.66[3 - 30]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
freeCashFlowPerShareTTM19.612.000.1950.389[0 - 20]
debtEquityRatioTTM1.430-1.5004.28-6.42[0 - 2.5]
grossProfitMarginTTM0.6671.0002.212.21[0.2 - 0.8]
operatingProfitMarginTTM0.2731.0006.536.53[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2561.0009.699.69[0.2 - 2]
assetTurnoverTTM0.5150.8009.907.92[0.5 - 2]
Total Score6.57

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM3.861.0009.710[1 - 100]
returnOnEquityTTM0.4242.507.699.60[0.1 - 1.5]
freeCashFlowPerShareTTM19.612.003.460.389[0 - 30]
dividendYielPercentageTTM0.05161.5008.710[0 - 0.4]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
payoutRatioTTM0.9571.5000.433-0.433[0 - 1]
pegRatioTTM2.061.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2211.0006.970[0.1 - 0.5]
Total Score5.74

Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.